共 50 条
- [21] Adjuvant radiotherapy (RT) and trastuzumab in stage I-IIA breast cancer: Toxicity data from North Central Cancer Treatment Group phase III trial N9831.JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 8S - 8SHalyard, M. Y.论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Scottsdale, AZ USAPisansky, T. M.论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Scottsdale, AZ USASolin, L. J.论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Scottsdale, AZ USAMarks, L. B.论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Scottsdale, AZ USAPierce, L. J.论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Scottsdale, AZ USADueck, A.论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Scottsdale, AZ USAPerez, E. A.论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Scottsdale, AZ USA
- [22] 5-year follow-up of the safety, tolerability and efficacy of subcutaneous trastuzumab for the adjuvant treatment of HER2-positive early breast cancer. Results from the SafeHER Phase III trialBREAST, 2021, 56 : S21 - S22Gligorov, J.论文数: 0 引用数: 0 h-index: 0机构: Sorbonne Univ, AP HP, Inst Univ Cancerol, Paris, France Sorbonne Univ, AP HP, Inst Univ Cancerol, Paris, FrancePivot, X.论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Jean Minjoz, Besancon, France Sorbonne Univ, AP HP, Inst Univ Cancerol, Paris, FranceAtaseven, B.论文数: 0 引用数: 0 h-index: 0机构: Kliniken Essen Mitte, Dept Gynecol & Gynecol Oncol, Essen, Germany Ludwig Maximilians Univ Munchen, Dept Obstet & Gynecol, Univ Hosp, Munich, Germany Sorbonne Univ, AP HP, Inst Univ Cancerol, Paris, FranceDe Laurentiis, M.论文数: 0 引用数: 0 h-index: 0机构: Fdn G Pascale, Div Breast Oncol, Ist Nazl Tumori, IRCCS, Naples, Italy Sorbonne Univ, AP HP, Inst Univ Cancerol, Paris, FranceLlombart, A.论文数: 0 引用数: 0 h-index: 0机构: Hosp Arnau Vilanova, Valencia, Spain Sorbonne Univ, AP HP, Inst Univ Cancerol, Paris, FranceJung, K. H.论文数: 0 引用数: 0 h-index: 0机构: Univ Ulsan, Asan Med Ctr, Coll Med, Seoul, South Korea Sorbonne Univ, AP HP, Inst Univ Cancerol, Paris, FranceManikhas, A.论文数: 0 引用数: 0 h-index: 0机构: Oncol Hosp St Petersburg, St Petersburg, Russia Sorbonne Univ, AP HP, Inst Univ Cancerol, Paris, FranceAzim, H. A.论文数: 0 引用数: 0 h-index: 0机构: Cairo Univ, Dept Clin Oncol, Cairo, Egypt Sorbonne Univ, AP HP, Inst Univ Cancerol, Paris, FranceAlexandrou, A.论文数: 0 引用数: 0 h-index: 0机构: F Hoffmann La Roche, Welwyn Garden City, England Sorbonne Univ, AP HP, Inst Univ Cancerol, Paris, FranceGupta, K.论文数: 0 引用数: 0 h-index: 0机构: IQVIA RDS India Pvt Ltd, Bangalore, Karnataka, India Sorbonne Univ, AP HP, Inst Univ Cancerol, Paris, FranceHerraez-Baranda, L.论文数: 0 引用数: 0 h-index: 0机构: F Hoffmann La Roche, Basel, Switzerland Sorbonne Univ, AP HP, Inst Univ Cancerol, Paris, FranceTosti, N.论文数: 0 引用数: 0 h-index: 0机构: F Hoffmann La Roche, Basel, Switzerland Sorbonne Univ, AP HP, Inst Univ Cancerol, Paris, FranceRestuccia, E.论文数: 0 引用数: 0 h-index: 0机构: F Hoffmann La Roche, Basel, Switzerland Sorbonne Univ, AP HP, Inst Univ Cancerol, Paris, France
- [23] A phase III trial of adjuvant neratinib (NER) after trastuzumab (TRAS) in women with early-stage HER2+breast cancer (BC).JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)Goss, P. E.论文数: 0 引用数: 0 h-index: 0机构: Massachusetts Gen Hosp, Boston, MA 02114 USABarrios, C. H.论文数: 0 引用数: 0 h-index: 0机构: Massachusetts Gen Hosp, Boston, MA 02114 USAChan, A.论文数: 0 引用数: 0 h-index: 0机构: Massachusetts Gen Hosp, Boston, MA 02114 USAChia, S. K. L.论文数: 0 引用数: 0 h-index: 0机构: Massachusetts Gen Hosp, Boston, MA 02114 USADelaloge, S.论文数: 0 引用数: 0 h-index: 0机构: Massachusetts Gen Hosp, Boston, MA 02114 USAEjlertsen, B.论文数: 0 引用数: 0 h-index: 0机构: Massachusetts Gen Hosp, Boston, MA 02114 USAIngle, J. N.论文数: 0 引用数: 0 h-index: 0机构: Massachusetts Gen Hosp, Boston, MA 02114 USAMoy, B.论文数: 0 引用数: 0 h-index: 0机构: Massachusetts Gen Hosp, Boston, MA 02114 USAIwata, H.论文数: 0 引用数: 0 h-index: 0机构: Massachusetts Gen Hosp, Boston, MA 02114 USAHolmes, F. A.论文数: 0 引用数: 0 h-index: 0机构: Massachusetts Gen Hosp, Boston, MA 02114 USAMansi, J.论文数: 0 引用数: 0 h-index: 0机构: Massachusetts Gen Hosp, Boston, MA 02114 USAVon Minckwitz, G.论文数: 0 引用数: 0 h-index: 0机构: Massachusetts Gen Hosp, Boston, MA 02114 USAHan, L.论文数: 0 引用数: 0 h-index: 0机构: Massachusetts Gen Hosp, Boston, MA 02114 USAThiele, A.论文数: 0 引用数: 0 h-index: 0机构: Massachusetts Gen Hosp, Boston, MA 02114 USAAgrapart, V.论文数: 0 引用数: 0 h-index: 0机构: Massachusetts Gen Hosp, Boston, MA 02114 USAFreyman, A.论文数: 0 引用数: 0 h-index: 0机构: Massachusetts Gen Hosp, Boston, MA 02114 USATruscello, J.论文数: 0 引用数: 0 h-index: 0机构: Massachusetts Gen Hosp, Boston, MA 02114 USABerkenblit, A.论文数: 0 引用数: 0 h-index: 0机构: Massachusetts Gen Hosp, Boston, MA 02114 USAFinkelstein, D.论文数: 0 引用数: 0 h-index: 0机构: Massachusetts Gen Hosp, Boston, MA 02114 USA
- [24] Tailored dose-dense chemotherapy in combination with trastuzumab as adjuvant therapy for HER2-positive breast cancer: A secondary analysis of the phase III PANTHER trial.JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)Foukakis, Theodoros论文数: 0 引用数: 0 h-index: 0机构: Karolinska Inst, Stockholm, SwedenPapakonstantinou, Antroula论文数: 0 引用数: 0 h-index: 0机构: Karolinska Inst, Stockholm, SwedenMatikas, Alexios论文数: 0 引用数: 0 h-index: 0机构: Karolinska Inst, Stockholm, SwedenBengtsson, Nils-Olof论文数: 0 引用数: 0 h-index: 0机构: Karolinska Inst, Stockholm, SwedenMalmstrom, Per论文数: 0 引用数: 0 h-index: 0机构: Karolinska Inst, Stockholm, SwedenHedayati, Elham论文数: 0 引用数: 0 h-index: 0机构: Karolinska Inst, Stockholm, SwedenSteger, Guenther G.论文数: 0 引用数: 0 h-index: 0机构: Karolinska Inst, Stockholm, SwedenUntch, Michael论文数: 0 引用数: 0 h-index: 0机构: Karolinska Inst, Stockholm, SwedenHubbert, Laila论文数: 0 引用数: 0 h-index: 0机构: Karolinska Inst, Stockholm, SwedenJohansson, Hemming论文数: 0 引用数: 0 h-index: 0机构: Karolinska Inst, Stockholm, SwedenHellstrom, Mats论文数: 0 引用数: 0 h-index: 0机构: Karolinska Inst, Stockholm, SwedenGnant, Michael论文数: 0 引用数: 0 h-index: 0机构: Karolinska Inst, Stockholm, SwedenLoibl, Sibylle论文数: 0 引用数: 0 h-index: 0机构: Karolinska Inst, Stockholm, SwedenGreil, Richard论文数: 0 引用数: 0 h-index: 0机构: Karolinska Inst, Stockholm, SwedenMoebus, Volker论文数: 0 引用数: 0 h-index: 0机构: Karolinska Inst, Stockholm, SwedenBergh, Jonas C. S.论文数: 0 引用数: 0 h-index: 0机构: Karolinska Inst, Stockholm, Sweden
- [25] First China-manufactured trastuzumab biosimilar HLX02 global phase III trial met primary endpoint in breast cancerANNALS OF ONCOLOGY, 2019, 30Xu, B.论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci, Internal Med, Canc Hosp, Beijing, Peoples R China Chinese Acad Med Sci, Internal Med, Canc Hosp, Beijing, Peoples R ChinaZhang, Q.论文数: 0 引用数: 0 h-index: 0机构: Harbin Med Univ, Internal Med, Canc Hosp, Harbin, Heilongjiang, Peoples R China Chinese Acad Med Sci, Internal Med, Canc Hosp, Beijing, Peoples R ChinaSun, T.论文数: 0 引用数: 0 h-index: 0机构: Liaoning Canc Hosp & Inst, Internal Med, Shenyang, Liaoning, Peoples R China Chinese Acad Med Sci, Internal Med, Canc Hosp, Beijing, Peoples R ChinaLi, W.论文数: 0 引用数: 0 h-index: 0机构: Jilin Univ, Bethune Hosp 1, Internal Med, Changchun, Jilin, Peoples R China Chinese Acad Med Sci, Internal Med, Canc Hosp, Beijing, Peoples R ChinaTeng, Y.论文数: 0 引用数: 0 h-index: 0机构: China Med Univ, Hosp 1, Internal Med, Shenyang, Liaoning, Peoples R China Chinese Acad Med Sci, Internal Med, Canc Hosp, Beijing, Peoples R ChinaHu, X.论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Shanghai Canc Ctr, Internal Med, Shanghai, Peoples R China Chinese Acad Med Sci, Internal Med, Canc Hosp, Beijing, Peoples R ChinaBondarenko, I.论文数: 0 引用数: 0 h-index: 0机构: MOHU, CI Dnipropetrovsk CMCH 4, Internal Med, Dnipropetrovsk RC Dept Chemotherapy SI Dnipropetr, Dnipo, Ukraine Chinese Acad Med Sci, Internal Med, Canc Hosp, Beijing, Peoples R ChinaAdamchuk, H.论文数: 0 引用数: 0 h-index: 0机构: DRC, 8CI Kryvyi Rih Oncol Dispensary, Internal Med, Dnepropetrovsk, Ukraine Chinese Acad Med Sci, Internal Med, Canc Hosp, Beijing, Peoples R ChinaLi, Y.论文数: 0 引用数: 0 h-index: 0机构: Shanghai Henlius Biotech Inc, Global Clin & Med Affairs, Shanghai, Peoples R China Chinese Acad Med Sci, Internal Med, Canc Hosp, Beijing, Peoples R ChinaShan, B.论文数: 0 引用数: 0 h-index: 0机构: Shanghai Henlius Biotech Inc, Global Clin & Med Affairs, Shanghai, Peoples R China Chinese Acad Med Sci, Internal Med, Canc Hosp, Beijing, Peoples R ChinaCheng, J.论文数: 0 引用数: 0 h-index: 0机构: Shanghai Henlius Biotech Inc, Global Clin & Med Affairs, Shanghai, Peoples R China Chinese Acad Med Sci, Internal Med, Canc Hosp, Beijing, Peoples R ChinaPeng, T.论文数: 0 引用数: 0 h-index: 0机构: Shanghai Henlius Biotech Inc, Global Clin & Med Affairs, Shanghai, Peoples R China Chinese Acad Med Sci, Internal Med, Canc Hosp, Beijing, Peoples R ChinaWang, X.论文数: 0 引用数: 0 h-index: 0机构: Shanghai Henlius Biotech Inc, Global Regulatory Affairs, Shanghai, Peoples R China Chinese Acad Med Sci, Internal Med, Canc Hosp, Beijing, Peoples R ChinaChen, Y.论文数: 0 引用数: 0 h-index: 0机构: Shanghai Henlius Biotech Inc, Global Regulatory Affairs, Shanghai, Peoples R China Chinese Acad Med Sci, Internal Med, Canc Hosp, Beijing, Peoples R ChinaJiang, W.论文数: 0 引用数: 0 h-index: 0机构: Shanghai Henlius Biotech Inc, Execut Off, Shanghai, Peoples R China Chinese Acad Med Sci, Internal Med, Canc Hosp, Beijing, Peoples R ChinaLiu, S.论文数: 0 引用数: 0 h-index: 0机构: Shanghai Henlius Biotech Inc, Execut Off, Shanghai, Peoples R China Chinese Acad Med Sci, Internal Med, Canc Hosp, Beijing, Peoples R ChinaZhang, X.论文数: 0 引用数: 0 h-index: 0机构: Shanghai Henlius Biotech Inc, Global Clin & Med Affairs, Shanghai, Peoples R China Chinese Acad Med Sci, Internal Med, Canc Hosp, Beijing, Peoples R ChinaLiu, E.论文数: 0 引用数: 0 h-index: 0机构: Shanghai Henlius Biotech Inc, Global Clin & Med Affairs, Shanghai, Peoples R China Chinese Acad Med Sci, Internal Med, Canc Hosp, Beijing, Peoples R ChinaLuk, A.论文数: 0 引用数: 0 h-index: 0机构: Shanghai Henlius Biotech Inc, Global Clin & Med Affairs, Shanghai, Peoples R China Chinese Acad Med Sci, Internal Med, Canc Hosp, Beijing, Peoples R ChinaWang, Q.论文数: 0 引用数: 0 h-index: 0机构: Shanghai Henlius Biotech Inc, Global Clin & Med Affairs, Shanghai, Peoples R China Chinese Acad Med Sci, Internal Med, Canc Hosp, Beijing, Peoples R China
- [26] Survival, Pathologic Response, and Genomics in CALGB 40601 (Alliance), a Neoadjuvant Phase III Trial of Paclitaxel-Trastuzumab With or Without Lapatinib in HER2-Positive Breast CancerJOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (35) : 4184 - +Fernandez-Martinez, Aranzazu论文数: 0 引用数: 0 h-index: 0机构: Univ N Carolina, Lineberger Comprehens Ctr, Chapel Hill, NC 27515 USA Univ N Carolina, Dept Genet, Chapel Hill, NC 27515 USA Univ N Carolina, Lineberger Comprehens Ctr, Chapel Hill, NC 27515 USAKrop, Ian E.论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Partners CancerCare, Dept Med Oncol, Boston, MA USA Univ N Carolina, Lineberger Comprehens Ctr, Chapel Hill, NC 27515 USAHillman, David W.论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Alliance Stat & Data Ctr, Rochester, MN USA Univ N Carolina, Lineberger Comprehens Ctr, Chapel Hill, NC 27515 USAPolley, Mei-Yin论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Alliance Stat & Data Ctr, Rochester, MN USA Univ N Carolina, Lineberger Comprehens Ctr, Chapel Hill, NC 27515 USAParker, Joel S.论文数: 0 引用数: 0 h-index: 0机构: Univ N Carolina, Lineberger Comprehens Ctr, Chapel Hill, NC 27515 USA Univ N Carolina, Dept Genet, Chapel Hill, NC 27515 USA Univ N Carolina, Lineberger Comprehens Ctr, Chapel Hill, NC 27515 USAHuebner, Lucas论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Alliance Stat & Data Ctr, Rochester, MN USA Univ N Carolina, Lineberger Comprehens Ctr, Chapel Hill, NC 27515 USAHoadley, Katherine A.论文数: 0 引用数: 0 h-index: 0机构: Univ N Carolina, Lineberger Comprehens Ctr, Chapel Hill, NC 27515 USA Univ N Carolina, Dept Genet, Chapel Hill, NC 27515 USA Univ N Carolina, Lineberger Comprehens Ctr, Chapel Hill, NC 27515 USAShepherd, Jonathan论文数: 0 引用数: 0 h-index: 0机构: Univ N Carolina, Lineberger Comprehens Ctr, Chapel Hill, NC 27515 USA Univ N Carolina, Dept Genet, Chapel Hill, NC 27515 USA Univ N Carolina, Lineberger Comprehens Ctr, Chapel Hill, NC 27515 USATolaney, Sara论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Partners CancerCare, Dept Med Oncol, Boston, MA USA Univ N Carolina, Lineberger Comprehens Ctr, Chapel Hill, NC 27515 USAHenry, N. Lynn论文数: 0 引用数: 0 h-index: 0机构: Univ Michigan, Rogel Canc Ctr, Ann Arbor, MI 48109 USA Univ N Carolina, Lineberger Comprehens Ctr, Chapel Hill, NC 27515 USADang, Chau论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA Univ N Carolina, Lineberger Comprehens Ctr, Chapel Hill, NC 27515 USAHarris, Lyndsay论文数: 0 引用数: 0 h-index: 0机构: NCI, Canc Diagnost Program, Bethesda, MD 20892 USA Univ N Carolina, Lineberger Comprehens Ctr, Chapel Hill, NC 27515 USABerry, Donald论文数: 0 引用数: 0 h-index: 0机构: MD Anderson Canc Ctr, Div Biostat, Houston, TX USA Univ N Carolina, Lineberger Comprehens Ctr, Chapel Hill, NC 27515 USA论文数: 引用数: h-index:机构:Hudis, Clifford论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA Univ N Carolina, Lineberger Comprehens Ctr, Chapel Hill, NC 27515 USAWiner, Eric论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Partners CancerCare, Dept Med Oncol, Boston, MA USA Univ N Carolina, Lineberger Comprehens Ctr, Chapel Hill, NC 27515 USAPartridge, Ann论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Partners CancerCare, Dept Med Oncol, Boston, MA USA Univ N Carolina, Lineberger Comprehens Ctr, Chapel Hill, NC 27515 USAPerou, Charles M.论文数: 0 引用数: 0 h-index: 0机构: Univ N Carolina, Lineberger Comprehens Ctr, Chapel Hill, NC 27515 USA Univ N Carolina, Dept Genet, Chapel Hill, NC 27515 USA Univ N Carolina, Lineberger Comprehens Ctr, Chapel Hill, NC 27515 USACarey, Lisa A.论文数: 0 引用数: 0 h-index: 0机构: Univ N Carolina, Lineberger Comprehens Ctr, Chapel Hill, NC 27515 USA Univ N Carolina, Div Hematol Oncol, 170 Manning Dr,CB7305, Chapel Hill, NC 27515 USA Univ N Carolina, Lineberger Comprehens Ctr, Chapel Hill, NC 27515 USA
- [27] Postoperative adjuvant chemotherapy followed by adjuvant tamoxifen versus nil for patients with operable breast cancer:: A randomised phase III trial of the European Organisation for Research and Treatment of Cancer Breast GroupEUROPEAN JOURNAL OF CANCER, 2007, 43 (02) : 331 - 340Morales, Leilani论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Gasthuisberg, Dept Gen Med Oncol, B-3000 Louvain, BelgiumCanney, Peter论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Gasthuisberg, Dept Gen Med Oncol, B-3000 Louvain, BelgiumDyczka, Jaroslaw论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Gasthuisberg, Dept Gen Med Oncol, B-3000 Louvain, BelgiumRutgers, Emiel论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Gasthuisberg, Dept Gen Med Oncol, B-3000 Louvain, BelgiumColeman, Robert论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Gasthuisberg, Dept Gen Med Oncol, B-3000 Louvain, BelgiumCufer, Tanja论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Gasthuisberg, Dept Gen Med Oncol, B-3000 Louvain, BelgiumWelnicka-Jaskiewicz, Marzena论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Gasthuisberg, Dept Gen Med Oncol, B-3000 Louvain, BelgiumNortier, Johan论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Gasthuisberg, Dept Gen Med Oncol, B-3000 Louvain, BelgiumBogaerts, Jan论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Gasthuisberg, Dept Gen Med Oncol, B-3000 Louvain, BelgiumTherasse, Patrick论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Gasthuisberg, Dept Gen Med Oncol, B-3000 Louvain, BelgiumParidaens, Robert论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Gasthuisberg, Dept Gen Med Oncol, B-3000 Louvain, Belgium
- [28] Phase III study of lapatinib after completion of adjuvant chemotherapy in trastuzumab-naive women with ErbB2-overexpressing breast cancer: Tykerb evaluation after chemotherapy (TEACH) studyBREAST, 2007, 16 : S47 - S47Moy, B.论文数: 0 引用数: 0 h-index: 0机构: Massachusetts Gen Hosp, Gillette Ctr Womens Canc, Boston, MA 02114 USA Massachusetts Gen Hosp, Gillette Ctr Womens Canc, Boston, MA 02114 USAMaltzman, J. D.论文数: 0 引用数: 0 h-index: 0机构: GlaxoSmithKline Inc, Collegeville, PA USA Massachusetts Gen Hosp, Gillette Ctr Womens Canc, Boston, MA 02114 USAGoss, P. E.论文数: 0 引用数: 0 h-index: 0机构: Massachusetts Gen Hosp, Gillette Ctr Womens Canc, Boston, MA 02114 USA Massachusetts Gen Hosp, Gillette Ctr Womens Canc, Boston, MA 02114 USA
- [29] Lapatinib Plus Capecitabine in Women with HER-2-Positive Advanced Breast Cancer: Final Survival Analysis of a Phase III Randomized TrialONCOLOGIST, 2010, 15 (09): : 924 - 934Cameron, David论文数: 0 引用数: 0 h-index: 0机构: Univ Leeds, Leeds, W Yorkshire, England Univ Leeds, Leeds, W Yorkshire, EnglandCasey, Michelle论文数: 0 引用数: 0 h-index: 0机构: GlaxoSmithKline Inc, Collegeville, PA USA Univ Leeds, Leeds, W Yorkshire, EnglandOliva, Cristina论文数: 0 引用数: 0 h-index: 0机构: Takeda Pharmaceut Co Ltd, London, England Univ Leeds, Leeds, W Yorkshire, EnglandNewstat, Beth论文数: 0 引用数: 0 h-index: 0机构: GlaxoSmithKline Inc, Collegeville, PA USA Univ Leeds, Leeds, W Yorkshire, EnglandImwalle, Bradley论文数: 0 引用数: 0 h-index: 0机构: Hlth Learning Syst, Parsippany, NJ USA Univ Leeds, Leeds, W Yorkshire, EnglandGeyer, Charles E.论文数: 0 引用数: 0 h-index: 0机构: Allegheny Gen Hosp, Dept Human Oncol, Pittsburgh, PA 15212 USA Univ Leeds, Leeds, W Yorkshire, England
- [30] 11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trialLANCET, 2017, 389 (10075): : 1195 - 1205Cameron, David论文数: 0 引用数: 0 h-index: 0机构: Univ Edinburgh, Canc Res Ctr, Western Gen Hosp, Edinburgh EH4 2XU, Midlothian, Scotland Univ Edinburgh, Canc Res Ctr, Western Gen Hosp, Edinburgh EH4 2XU, Midlothian, ScotlandPiccart-Gebhart, Martine J.论文数: 0 引用数: 0 h-index: 0机构: Univ Libre Bruxelles, Dept Med, Brussels, Belgium Univ Edinburgh, Canc Res Ctr, Western Gen Hosp, Edinburgh EH4 2XU, Midlothian, ScotlandGelber, Richard D.论文数: 0 引用数: 0 h-index: 0机构: Harvard TH Chan Sch Publ Hlth, Dept Biostat & Computat Biol, Dana Farber Canc Inst, Harvard Med Sch, Boston, MA USA Frontier Sci & Technol Res Fdn Inc, Boston, MA USA Univ Edinburgh, Canc Res Ctr, Western Gen Hosp, Edinburgh EH4 2XU, Midlothian, ScotlandProcter, Marion论文数: 0 引用数: 0 h-index: 0机构: Frontier Sci Scotland Ltd, Kincraig, Kingussie, Scotland Univ Edinburgh, Canc Res Ctr, Western Gen Hosp, Edinburgh EH4 2XU, Midlothian, ScotlandGoldhirsch, Aron论文数: 0 引用数: 0 h-index: 0机构: European Inst Oncol, Milan, Italy Univ Edinburgh, Canc Res Ctr, Western Gen Hosp, Edinburgh EH4 2XU, Midlothian, Scotlandde Azambuja, Evandro论文数: 0 引用数: 0 h-index: 0机构: Univ Libre Bruxelles, Med Oncol Clin, Brussels, Belgium Univ Edinburgh, Canc Res Ctr, Western Gen Hosp, Edinburgh EH4 2XU, Midlothian, ScotlandCastro, Gilberto, Jr.论文数: 0 引用数: 0 h-index: 0机构: Univ Sao Paulo, Clin Oncol, Inst Canc Estado Sao Paulo, Fac Med, Sao Paulo, Brazil Univ Edinburgh, Canc Res Ctr, Western Gen Hosp, Edinburgh EH4 2XU, Midlothian, ScotlandUntch, Michael论文数: 0 引用数: 0 h-index: 0机构: Helios Klinikum Berlin Buch, Multidisciplinary Breast Canc Ctr, Berlin, Germany Univ Edinburgh, Canc Res Ctr, Western Gen Hosp, Edinburgh EH4 2XU, Midlothian, ScotlandSmith, Ian论文数: 0 引用数: 0 h-index: 0机构: Royal Marsden Hosp, Breast Unit, London, England Inst Canc Res, London, England Univ Edinburgh, Canc Res Ctr, Western Gen Hosp, Edinburgh EH4 2XU, Midlothian, ScotlandGianni, Luca论文数: 0 引用数: 0 h-index: 0机构: Hosp San Raffaele, Dept Med Oncol, Inst Sci, Milan, Italy Univ Edinburgh, Canc Res Ctr, Western Gen Hosp, Edinburgh EH4 2XU, Midlothian, ScotlandBaselga, Jose论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA Univ Edinburgh, Canc Res Ctr, Western Gen Hosp, Edinburgh EH4 2XU, Midlothian, ScotlandAl-Sakaff, Nedal论文数: 0 引用数: 0 h-index: 0机构: F Hoffmann La Roche, Basel, Switzerland Univ Edinburgh, Canc Res Ctr, Western Gen Hosp, Edinburgh EH4 2XU, Midlothian, ScotlandLauer, Sabine论文数: 0 引用数: 0 h-index: 0机构: F Hoffmann La Roche, Basel, Switzerland Univ Edinburgh, Canc Res Ctr, Western Gen Hosp, Edinburgh EH4 2XU, Midlothian, ScotlandMcFadden, Eleanor论文数: 0 引用数: 0 h-index: 0机构: Frontier Sci Scotland Ltd, Kincraig, Kingussie, Scotland Univ Edinburgh, Canc Res Ctr, Western Gen Hosp, Edinburgh EH4 2XU, Midlothian, ScotlandLeyland-Jones, Brian论文数: 0 引用数: 0 h-index: 0机构: Avera Canc Inst, Ctr Precis Oncol, Sioux Falls, SD USA Univ Edinburgh, Canc Res Ctr, Western Gen Hosp, Edinburgh EH4 2XU, Midlothian, ScotlandBell, Richard论文数: 0 引用数: 0 h-index: 0机构: Deakin Univ, Waurn Ponds, Vic, Australia Univ Edinburgh, Canc Res Ctr, Western Gen Hosp, Edinburgh EH4 2XU, Midlothian, ScotlandDowsett, Mitch论文数: 0 引用数: 0 h-index: 0机构: Royal Marsden Hosp, Breast Unit, London, England Inst Canc Res, London, England Univ Edinburgh, Canc Res Ctr, Western Gen Hosp, Edinburgh EH4 2XU, Midlothian, ScotlandJackisch, Christian论文数: 0 引用数: 0 h-index: 0机构: Sana Klinikum Offenbach, Dept Gynecol & Obstet, Offenbach, Germany Univ Edinburgh, Canc Res Ctr, Western Gen Hosp, Edinburgh EH4 2XU, Midlothian, Scotland